Positive Serologic Test for Hepatitis B Virus (HBV)
Hepatitis B virus infection
False-positive serologic test for hepatitis B virus
Suggested Additional Lab Testing
Acute hepatitis B
Patient is positive for IgM antibody to HBV core antigen.
Patient is usually positive for hepatitis B surface antigen and hepatitis B virus e antigen. Presence of the e antigen indicates a high degree of infectivity.
Patient is likely to be positive for serum HBV DNA; level can be followed to assess response to therapy.
Chronic hepatitis B
Liver function tests, especially aminotransferases, are likely to be elevated for more than 6 months.
Hepatitis B surface antigen is positive for more than 6 months.
Chronic cases are also positive for anti-HBV core antigen as total antibody or as IgG.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Patient-Reported Outcomes in Oncology Expected to Make Regulatory Waves
- Metastatic Prostate Cancer Responds to Novel Radiation Therapy
- FDA Provides Update on Breast Implant-Associated Anaplastic Large Cell Lymphoma
- Q&A With Mark B. Gerstein, PhD, on Diagnostic Genomic vs Exomic Sequencing
- Immune Signature for Renal Cell Papillary Carcinoma Predicts Outcome
- Nivolumab-Ipilimumab Survival Benefit in Advanced RCC Confirmed
- Two-Drug Combination Superior to Sunitinib in Patients With Untreated Advanced Renal Cell Carcinoma
- Adding Chemotherapy to Radiation Post-Radical Cystectomy Improves Survival in Urothelial Carcinoma
- Radiation, Chemotherapy Not Beneficial in Localized Upper Tract Urothelial Carcinoma
- Radical Cystectomy Superior to Trimodal Therapy for Muscle-Invasive Bladder Cancer